Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0002050709-25-000007·PALISADE BIO, INC.
Schedule 13G ownership disclosure
Palisade Bio, Inc.
Common Stock, par value $0.01 per share · CUSIP: 696389402
Event date: 2025-10-01
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Squadron Master Fund LP
Shares: 7,308,580.00 · Class: 7.6%
- Squadron Capital Management LLC
Shares: 8,250,000.00 · Class: 8.5%
- Matthew Sesterhenn
Shares: 8,250,000.00 · Class: 8.5%
- William Blank
Shares: 8,250,000.00 · Class: 8.5%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0002050709-25-000007
- Form type
- SCHEDULE 13G
- Filer
- PALISADE BIO, INC.
- CIK
- CIK 1357459
- Filed
- Oct 08, 2025
- Reporting period
- Oct 01, 2025
- Description
- Schedule 13G beneficial ownership